On Tuesday, the US administration granted Payzer to exempt three years of customs duties, in an agreement whereby the giant pharmaceutical company voluntarily reduces the prices of unlimited drugs in the United States.
President Donald Trump, who was surrounded by a number of health officials, did not provide many details about what the drugs are or their number.
The advertisement comes within the framework of Trump’s efforts to conclude pricing deals for the “first country to care” with pharmaceutical companies, which will allow these companies to link the prices of medicines in the United States to the lowest cost of medicines in other rich countries.
The White House also announced that it will unveil a website, “TrumpRX”, allowing consumers to buy some medications directly at reduced prices.
After the announcement, the Pharaoh’s shares increased by 5%.
Similar to Trump, the CEO of Vizar Albert Burla praised the decision, considering it a great achievement, despite the issuance of a statement by the company that did not include little details.
The company reported that a “large majority” can be provided with “primary health care treatments and some specialized brands chosen” with discounts between 50% and 85%.
Trump also announced that Pfizer agreed to “invest $ 70 billion to return local manufacturing facilities” to the United States.